I-Costochondritis

Zonke izimbambo zakho ezi-2 eziphansi zixhunywe esifubeni sakho ngoqwanga. Le uqwanga lungasha futhi lubangele ubuhlungu. Lesi simo sibizwa nge- costochondritis. Kuyimbangela ejwayelekile yobuhlungu besifuba.

Imvamisa asikho isizathu esaziwayo se-costochondritis. Kepha kungabangelwa:

• Ukulimala kwesifuba
• Ukuzivocavoca kanzima noma ukuphakamisa okunzima
• Ukutheleleka ngegciwane, njengezifo zokuphefumula
• Nciphisa ukukhwehlela
• Ukutheleleka ngemuva kokuhlinzwa noma ekusetshenzisweni kwezidakamizwa kwe-IV
• Ezinye izinhlobo zesifo samathambo

Izimpawu ezivame kakhulu ze-costochondritis ubuhlungu nobumnene esifubeni. Ungazizwa:

• Ubuhlungu obucijile ngaphambili kodonga lwesifuba sakho, obungahle buyele emuva noma esiswini
• Ukwanda kobuhlungu lapho uthatha umoya ojulile noma ukukhwehlela
• Ubumnene lapho ucindezela indawo lapho ubambo lujoyina khona ithambo lesifuba
• Ubuhlungu obuncane lapho uyeka ukunyakaza uphefumule buthule

Umhlinzeki wakho wokunakekelwa kwezempilo uzothatha umlando wakho wezokwelapha futhi enze ukuhlolwa komzimba. Indawo lapho izimbambo zihlangana khona nesifuba sesifuba iyahlolwa. Uma le ndawo ithambile futhi ibuhlungu, i-costochondritis iyona imbangela enkulu yesifo sakho esifubeni.

I-x-ray yesifuba ingenziwa uma izimpawu zakho zinzima noma zingathuthuki ngokwelashwa.

Umhlinzeki wakho futhi anga-oda izivivinyo ukukhipha ezinye izimo, njengokuhlaselwa yinhliziyo.

I-Costochondritis ivame ukuzihambela yodwa ezinsukwini noma emasontweni ambalwa. Kungathatha futhi izinyanga ezimbalwa. Ukwelashwa kugxile ekudambiseni izinhlungu.

• Sebenzisa ukucindezela okushisayo noma okubandayo.
• Gwema izinto ezenza izinhlungu zibe zimbi kakhulu.

Imithi yezinhlungu, njenge-ibuprofen (Advil, Motrin) noma naproxen (Aleve), ingasiza ekudambiseni ubuhlungu nokuvuvukala. Ungazithenga ngaphandle kadokotela.

• Khuluma nomhlinzeki wakho ngaphambi kokusebenzisa le mithi uma unesifo senhliziyo, umfutho wegazi ophakeme, isifo sezinso, isifo sesibindi, noma uke waba nezilonda zesisu noma ukopha ngaphakathi esikhathini esedlule.
• Thatha umthamo ngokwelulekwa ngumhlinzeki. Ungathathi ngaphezu kwenani elinconywe ebhodleleni. Funda ngokucophelela izexwayiso ezikulebula ngaphambi kokuthatha noma imuphi umuthi.

Ungase futhi uthathe i-acetaminophen (Tylenol) esikhundleni salokho, uma umhlinzeki wakho ekutshela ukuthi kuphephile ukwenza njalo. Abantu abanesifo sesibindi akufanele bathathe lo muthi.

Uma ubuhlungu bakho bukhulu, umhlinzeki wakho angakunikeza umuthi wezinhlungu onamandla.

Kwezinye izimo, umhlinzeki wakho angancoma ukwelashwa ngokomzimba.

Ubuhlungu be-Costochondritis buvame ukuphela ezinsukwini noma emasontweni ambalwa.

Shayela ku-911 noma uye egumbini lakho lezimo eziphuthumayo ngokushesha uma unesihlungu esifubeni. Ubuhlungu be-costochondritis bungafana nobuhlungu bokuhlaselwa yinhliziyo.

Uma usuvele utholakale une-costochondritis, shayela umhlinzeki wakho uma unezinye zalezi zimpawu ezilandelayo:

• Ukuphefumula kanzima
• Umkhuhlane omkhulu
• Noma yiziphi izimpawu zokutheleleka ezifana nobomvu, ubomvu, noma ukuvuvukala ezungeze izimbambo zakho
• Ubuhlungu obuqhubekayo noma obubi kakhulu ngemuva kokuphuza umuthi wezinhlungu
• Ubuhlungu obucijile ngawo wonke umoya

Ngoba imbangela ivame ukungaziwa, ayikho indlela eyaziwayo yokuvimbela i-costochondritis.

Ubuhlungu besifuba esifubeni; I-Costosternal syndrome; Izindleko zangaphandle chondrodynia; Ubuhlungu besifuba - i-costochondritis

• Ukudla okunomsoco - izinkinga zokuphatha izingane

• Izimbambo ne-anatomy yamaphaphu

Imamura M, Cassius DA. I-Costosternal syndrome. Ku: Frontera WR, iSilver JK, uRizzo TD, ama-eds.Okubalulekile Kwemithi Yomzimba Nokuvuselelwa. 3rd ed. IPhiladelphia, PA: Elsevier Saunders; 2015: isahluko 100.

Imamura M, Imamura ST. I-Tietze syndrome. Ku: Frontera WR, iSilver JK, uRizzo TD, ama-eds.Okubalulekile Kwemithi Yomzimba Nokuvuselelwa. 3rd ed. IPhiladelphia, PA: Elsevier Saunders; 2015: isahluko 116.

IShrestha A. Costochondritis. Ku: Ferri FF, ed. Umeluleki Wemitholampilo kaFerri 2019. IPhiladelphia, PA: Elsevier; 2019: 388-388.